Pharma Faces Investor Woes and Tariff Threats, Turns to AI and Collaboration for Survival

Industry leaders say uncertainty in funding, clinical development and manufacturing is driving companies to embrace digital transformation, streamlined operations and strategic partnerships to navigate a turbulent market and global tariff pressures.